A recurrent mutation in PALB2 in Finnish cancer families
Hannele Erkko(Oulu University Hospital), Robert Winqvist(Oulu University Hospital), Arja Jukkola‐Vuorinen(University of Oulu), Lauri A. Aaltonen(Varsinais-Suomen Sairaanhoitopiiri), Anne Kallioniemi(University of California, San Francisco), David M. Livingston(Dana-Farber Cancer Institute), Guilan Li(University of North Carolina at Chapel Hill), Katri Pylkäs(University of Oulu), Daniel A. Haber(Howard Hughes Medical Institute), Daphne W. Bell(National Institutes of Health), Qing Sheng(Zhejiang Sci-Tech University), Vesa Kataja(Kuopio University Hospital), Alexander Miron(Harvard University), Ronny Drapkin(University of Pennsylvania), Kirsi Syrjäkoski(Tampere University Hospital), Johanna Schleutker(University of Turku), Henna Mattila(Tampere University Hospital), Mervi Reiman(University of Oulu), Aki Mustonen(University of Oulu), Mervi Grip(University of Oulu), Jenni Nikkilä(University of Oulu), Bing Xia(Rutgers, The State University of New Jersey), Juha Kere(University of Helsinki), Veli-Matti Kosma(University of Eastern Finland), Katrin Rapakko(University of Oulu), Ylermi Soini(Oulu University Hospital), Sanna‐Maria Karppinen(University of Oulu)
Cited by 461
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
Isolation of rare circulating tumour cells in cancer patients by microchip technology
|Nature|2007|3.5k